O'Shaughnessy Asset Management, LLC Cardiff Oncology, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$5.18 - $7.24 $5,034 - $7,037	-972 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$5.01 - $7.58 $210 - $318	-42 Reduced 4.14%	972 $6,000
Q2 2021 Aug 09, 2021	SELL	$6.65 - $10.04 $425 - $642	-64 Reduced 5.94%	1,014 $7,000
Q1 2021 May 14, 2021	BUY	$9.1 - $19.57 $8,927 - $19,198	981 Added 1011.34%	1,078 $10,000
Q4 2020 Feb 11, 2021	BUY	$12.02 - $24.71 $1,165 - $2,396	97 New	97 $2,000

12.4M

813K

91.1K

Ticker CRDF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,334,900
Market Cap $195M
Description
Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.